During the past decade, ACTS Adult Addiction Receiving Facility (AARF) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ACTS Adult Addiction Receiving Facility (AARF)" #1 collaborator was "Cambridge Health Alliance" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ACTS Adult Addiction Receiving Facility (AARF)" are "Opioid-use Disorder" (2 trials). Many other conditions were trialed in "ACTS Adult Addiction Receiving Facility (AARF)" in a lesser frequency.

Most popular intervention types in "ACTS Adult Addiction Receiving Facility (AARF)" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "MySafeRx Inspire Flex" (1 trials), "MySafeRx Inspire Plus" (1 trials), "MySafeRx™" (1 trials) and "Standard Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "ACTS Adult Addiction Receiving Facility (AARF)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "ACTS Adult Addiction Receiving Facility (AARF)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in ACTS Adult Addiction Receiving Facility (AARF), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ACTS Adult Addiction Receiving Facility (AARF), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".